Search Results
30 items found for " trabecular bone"
Posts (24)
- 📰 GPCR Weekly News, May 6 to 12, 2024
GPCRs in Oncology and Immunology Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone The orphan G protein-coupled receptor 141
- FSH and bone: Comparison between males with central versus primary hypogonadism
The present study aims to investigate the possible role of FSH excess in male bone health, by comparing
- Murine bone marrow macrophages and human monocytes do not express atypical chemokine receptor 1
., 2017 ), including those lining bone marrow (BM) sinusoids ( Duchene et al., 2017 ).
Other Pages (6)
- Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
bone but not fibrosis in a murine model with fibrotic bone Published date May 1, 2024 Abstract "G protein-coupled Fibrous dysplasia (FD) of the bone is characterized by fibrotic, expansile bone lesions caused by activating Bone fibrosis remained evident after treatment. Notably, LGK974 caused significant bone loss in control mice. disease , fibrous dysplasia (FD) , osteoblasts , trabecular bone , G-protein coupled receptor signaling
- Student Flash Presentations
Mechanism Adgrg6/Gpr126 is Required for Myocardial Notch Activity and N-cadherin Localization to Attain Trabecular Bernadyn Adgrg6/Gpr126 is Required for Myocardial Notch Activity and N-cadherin Localization to Attain Trabecular
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Bone marrow (BM) samples were collected at baseline for genomic and transcriptomic analysis (n = 32). remission, with or without hematologic count recovery (CR/CRi), and 32% exhibited a ≥50% reduction in bone